STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$312,075
-55.8%
15,164
+1.1%
0.00%
-50.0%
Q2 2023$705,488
+1.0%
15,004
-9.9%
0.00%0.0%
Q1 2023$698,382
+10.0%
16,6440.0%0.00%0.0%
Q4 2022$634,802
-23.4%
16,644
-21.4%
0.00%0.0%
Q3 2022$829,000
+21.2%
21,1640.0%0.00%0.0%
Q2 2022$684,000
-75.4%
21,164
-74.8%
0.00%
-60.0%
Q1 2022$2,785,000
-22.9%
84,140
-1.0%
0.01%
-16.7%
Q4 2021$3,614,000
-4.5%
84,950
-0.5%
0.01%
-14.3%
Q3 2021$3,785,000
-25.5%
85,412
-4.5%
0.01%
-30.0%
Q2 2021$5,078,000
-4.5%
89,392
+25.9%
0.01%
-9.1%
Q1 2021$5,316,000
-22.0%
71,028
-9.8%
0.01%
-21.4%
Q4 2020$6,815,000
+37.0%
78,778
-3.2%
0.01%
+27.3%
Q3 2020$4,974,000
+65.1%
81,373
+12.3%
0.01%
+57.1%
Q2 2020$3,013,000
+53.6%
72,463
+6.1%
0.01%
+16.7%
Q1 2020$1,961,000
-59.7%
68,266
+1.2%
0.01%
-50.0%
Q4 2019$4,871,000
-48.9%
67,477
-0.8%
0.01%
-52.0%
Q3 2019$9,539,000
-24.6%
67,997
-1.6%
0.02%
-24.2%
Q2 2019$12,656,000
+27.6%
69,125
+10.8%
0.03%
+26.9%
Q1 2019$9,920,000
+67.1%
62,371
+0.6%
0.03%
+44.4%
Q4 2018$5,937,000
-23.9%
61,981
+12.2%
0.02%
-10.0%
Q3 2018$7,803,000
-8.5%
55,242
+1.4%
0.02%
-13.0%
Q2 2018$8,525,000
+133.7%
54,461
+140.4%
0.02%
+130.0%
Q1 2018$3,648,000
+5.5%
22,651
+7.9%
0.01%
+11.1%
Q4 2017$3,458,000
+229.3%
20,992
+24.6%
0.01%
+200.0%
Q3 2017$1,050,000
+3.4%
16,852
+32.3%
0.00%0.0%
Q2 2017$1,015,000
+18.4%
12,742
+5.7%
0.00%
+50.0%
Q1 2017$857,000
+39.1%
12,0560.0%0.00%0.0%
Q4 2016$616,000
+18.9%
12,056
+7.1%
0.00%0.0%
Q3 2016$518,000
+66.6%
11,256
+9.1%
0.00%
+100.0%
Q2 2016$311,000
+42.0%
10,316
+51.2%
0.00%0.0%
Q1 2016$219,000
-43.8%
6,822
+1.9%
0.00%0.0%
Q4 2015$390,000
+45.5%
6,692
+5.9%
0.00%0.0%
Q3 2015$268,000
-8.8%
6,322
+57.2%
0.00%0.0%
Q2 2015$294,0004,0210.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders